Impax Laboratories to Ring NASDAQ Opening Bell

August 24, 2009

HAYWARD, Calif.--(BUSINESS WIRE)--Aug. 24, 2009-- Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that Larry Hsu, Ph.D., President and Chief Executive Officer of Impax Laboratories, Inc., will preside over the NASDAQ Opening Bell on Monday, August 24, 2009 at the NASDAQ MarketSite® in New York City’s Times Square.

Larry Hsu, Ph.D., said: “Our relisting on the NASDAQ Global Market in March 2009 was an exciting time for Impax in re-establishing itself as a public company. I am honored to ring the NASDAQ Opening Bell as it represents a tremendous amount of achievement due to the dedication and hard work of our employees. This dedication has led to strong growth at the Company and will continue to be the driving force behind the successful execution of our dual-focus strategy and long-term value creation.”

The event will be broadcast live on national business television at 9:30 a.m. EST, as well as webcast live on NASDAQ’s Web site and on the NASDAQ MarketSite® Tower in New York City’s Times Square.

About Impax Laboratories, Inc.:

Impax Laboratories, Inc. is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products. Impax markets its generic products through its Global Pharmaceuticals division and markets its branded products through the Impax Pharmaceuticals division. Additionally, where strategically appropriate, Impax has developed marketing partnerships to fully leverage its technology platform. Impax Laboratories is headquartered in Hayward, California, and has a full range of capabilities in its Hayward and Philadelphia facilities. For more information, please visit the Company's Web site at:


The NASDAQ OMX Group, Inc. is the world's largest exchange company. It delivers trading, exchange technology and public company services across six continents, with over 3,700 listed companies. NASDAQ OMX Group offers multiple capital raising solutions to companies around the globe, including its U.S. listings market; NASDAQ OMX Nordic, NASDAQ OMX Baltic, NASDAQ OMX First North; and the U.S. 144A sector. The company offers trading across multiple asset classes including equities, derivatives, debt, commodities, structured products and ETFs.

NASDAQ OMX Group technology supports the operations of over 70 exchanges, clearing organizations and central securities depositories in more than 50 countries. NASDAQ OMX Nordic and NASDAQ OMX Baltic are not legal entities but describe the common offering from NASDAQ OMX Group exchanges in Helsinki, Copenhagen, Stockholm, Iceland, Tallinn, Riga, and Vilnius. For more information about NASDAQ OMX, visit

Source: Impax Laboratories, Inc.

Impax Laboratories, Inc.
Mark Donohue, 215-933-3526
Sr. Director Investor Relations